Department of Biochemistry, University of Vermont, College of Medicine, Colchester, Vermont.
Mechanical Engineering Department, University of Vermont, College of Engineering and Mathematical Sciences, Burlington, Vermont.
Biophys J. 2011 Feb 2;100(3):765-773. doi: 10.1016/j.bpj.2010.12.3720.
The generation of proteolyzed prothrombin species by preassembled prothrombinase in phospholipid-coated glass capillaries was studied at physiologic shear rates (100-1000 s(-1)). The concentration of active thrombin species (α-thrombin and meizothrombin) reaches a steady state, which varies inversely with shear rate. When corrected for shear rate, steady-state levels of active thrombin species exhibit no variation and a Michaelis-Menten analysis reveals that chemistry of this reaction is invariant between open and closed systems; collectively, these data imply that variations with shear rate arise from dilutional effects. Significantly, the major products observed include nonreactive species arising from the loss of prothrombin's phospholipid binding domain (des F1 species). A numerical model developed to investigate the spatial and temporal distribution of active thrombin species within the capillary reasonably approximates the observed output of total thrombin species at different shears; it also predicts concentrations of active thrombin species in the wall region sufficient to account for observed levels of des FI species. The predominant feedback formation of nonreactive species and high levels of the primarily anticoagulant intermediate meizothrombin (∼40% of total active thrombin species) may provide a mechanism to prevent thrombus propagation downstream of a site of thrombosis or hemorrhage.
在生理剪切速率(100-1000 s(-1))下,研究了预组装凝血酶原酶在磷脂涂层玻璃毛细管中对蛋白水解原凝血酶的生成。活性凝血酶(α-凝血酶和糜凝血酶)的浓度达到稳定状态,其与剪切速率呈反比。当对剪切速率进行校正时,活性凝血酶的稳态水平没有变化,米氏分析表明该反应的化学性质在开放系统和封闭系统之间是不变的;总的来说,这些数据表明,剪切速率的变化是由于稀释效应引起的。值得注意的是,观察到的主要产物包括失去凝血酶磷脂结合域的无反应性物质(des F1 物质)。为研究活性凝血酶在毛细管内的时空分布而开发的数值模型合理地模拟了在不同剪切下观察到的总凝血酶产物的输出;它还预测了在壁区的活性凝血酶的浓度,足以解释观察到的 des FI 物质的水平。非反应性物质的主要反馈形成和主要抗凝剂中间产物糜凝血酶(约占总活性凝血酶的 40%)的高浓度可能为防止血栓形成或出血部位下游血栓的传播提供了一种机制。